Johnson Investment Counsel Inc Reata Pharmaceuticals Inc Transaction History

Johnson Investment Counsel Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $107,018 - $323,206	3,469 New	3,469 $315,000
Q4 2021 Feb 15, 2022	SELL	$25.61 - $110.96 $88,841 - $384,920	-3,469 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $31,308 - $60,516	-400 Reduced 10.34%	3,469 $491,000
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $28,504 - $38,300	400 Added 11.53%	3,869 $311,000
Q1 2019 May 13, 2019	BUY	$51.9 - $101.79 $180,041 - $353,109	3,469 New	3,469 $296,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $76.44 $169,148 - $265,170	-3,469 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $123,635 - $319,356	3,469 New	3,469 $283,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.